FDA Inspection 1005288 — Ferndale Laboratories, Inc.

Ferndale Laboratories, Inc. — FEI 1811212

The FDA completed an inspection of Ferndale Laboratories, Inc. on February 3, 2017 in Ferndale, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ferndale, MI (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed